Podcasts
-
FDA ends GLP-1 compounding for semaglutide, tirzepatide
The FDA’s decision to end temporary compounding permissions for GLP-1 drugs like semaglutide and tirzepatide pushes patients into insurance and prescription challenges.
-
Advancing reproductive choices for men
Male contraception has remained stagnant for decades, but Plan A introduces a long-acting, reversible solution that could transform reproductive health options.
-
Understanding pharmacists' role in contraceptive access
Although regulations differ between states, in some areas, pharmacists play a critical role in contraceptive access, helping patients who might not otherwise have access to care.
-
Regulating and monitoring the online GLP-1 market
The booming GLP-1 market is transforming healthcare while raising regulatory concerns, with efforts underway to ensure safety in the online space.
-
Exploring gaps in GLP-1 research, care and coverage
Dr. Lydia Alexander discusses progress in obesity management and identifies gaps in GLP-1 research, care delivery and insurance coverage on 'Healthcare Strategies.'